Chanda et al. investigated the effects of sustained OPG-Fc expression using a recombinant adeno-associated viral vector in a mouse model of osteolytic breast cancer, finding a significant reduction in skeletal tumor growth and bone loss, despite no effects on long-term survival [145]. Here, TNFRSF11B is linked to breast cancer.